FDA Joins Forces With Customs Office To Beef Up Scrutiny of Drug Packages At Borders

The US FDA and the US customs office have agreed to team up and establish an expanded scientific presence at International Mail Facility locations deemed “high risk” ports of entry to deter illegal opioids and counterfeit drugs from entering US borders.